v3.25.4
Consolidated Statements of Operations (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Stock-based compensation expense $ 23,579 $ 35,377 $ 41,185
Cost of Revenue      
Stock-based compensation expense 2,558 3,533 4,949
Sales and Marketing      
Stock-based compensation expense 6,518 9,252 13,474
Research and Development      
Stock-based compensation expense 9,338 13,614 13,478
General and Administrative      
Stock-based compensation expense $ 5,625 $ 10,000 $ 9,785